Exact Sciences Corporation, incorporated on February 10, 1995, is a molecular diagnostics company. The Company focuses on the early detection and prevention of some forms of cancer. The Company offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer. Its Cologuard test is a stool-based deoxyribonucleic acid (sDNA) screening test, which utilizes a multi-target approach to detect deoxyribonucleic acid (DNA) and hemoglobin biomarkers associated with colorectal cancer and pre-cancer.
The Cologuard test is intended for the qualitative detection of colorectal neoplasia associated DNA markers and for the presence of occult hemoglobin in human stool. Its Cologuard test is indicated to screen men and women of 50 years or older. The Company focuses on the development of additional tests for other types of cancer. It is developing a blood-based biomarker test to aid in the early detection of lung cancer in individuals with lung nodules discovered through a computerized tomography (CT) or other scan.
The Company competes with Epigenomics AG, Applied Proteomics, Inc., Gene News, EDP Biotech Corporation, Illumina, Inc. and Quest Diagnostics.
441 Charmany Dr
The company trades on NASDAQ exchange. The company headquarter is located in Massachusetts, MA. The company was established in the 1995.| Ticker | EXAS |
| Long Name | Exact Sciences Corporation |
| Short Name | Exact Sciences |